Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has executed transactions under its share buy-back program launched on June 2, 2026, repurchasing 331,973 shares for approximately DKK 60.1 million at an average price of DKK 181.11 per share. The company now holds 3,069,957 treasury shares, representing 3.87% of its share capital.

06/22/2026, 2:53 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S has completed additional share repurchases under its DKK 150 million buy-back program initiated on June 2, 2026. Between June 15-19, 2026, the company repurchased 140,000 shares at an average price of DKK 180.58, bringing total accumulated repurchases to 331,973 shares (3.87% of share capital) valued at DKK 60.1 million.

06/22/2026, 2:53 AM • GlobeNewswire

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has repurchased 146,973 shares under its DKK 150 million buy-back program launched on June 2, 2026, spending approximately DKK 26.7 million at an average price of DKK 181.75 per share. The company now holds 2,884,957 treasury shares, representing 3.64% of its share capital.

06/15/2026, 2:44 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S has completed transactions under its share buy-back program initiated on June 2, 2026, repurchasing 146,973 shares at an average price of DKK 181.75 per share for a total value of DKK 26.7 million. The company now holds 2,884,957 treasury shares, representing 3.64% of its share capital. The buy-back program, running through July 10, 2026, is authorized to repurchase up to DKK 150 million in shares.

06/15/2026, 2:44 AM • GlobeNewswire

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has executed transactions under its share buy-back program launched on June 2, 2026, repurchasing 50,169 shares at an average price of DKK 182.35 per share for a total of DKK 9,148,515. The company now holds 2,788,153 treasury shares, representing 3.52% of its share capital.

06/08/2026, 2:55 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S has executed the first phase of its share buyback program, repurchasing 50,169 shares at an average price of DKK 182.35 between June 2-4, 2026. The company now holds 2,788,153 treasury shares representing 3.52% of its share capital. The buyback program, valued at up to DKK 150 million, will run through July 10, 2026.

06/08/2026, 2:55 AM • GlobeNewswire

Bavarian Nordic Announces Interim Results for the First Three Months of 2026

Bavarian Nordic announced Q1 2026 revenue of DKK 1,058 million, with Travel Health growing 14% year-over-year driven by rabies and chikungunya vaccines, while Public Preparedness declined 53% as expected in a normalized year. The company upgraded its full-year guidance to DKK 5,500-5,700 million revenue with ~28% EBITDA margin following a USD 97 million contract award from the U.S. Government for freeze-dried smallpox vaccine production.

05/13/2026, 1:35 AM • GlobeNewswire

Bavarian Nordic offentliggør delårsregnskab for første kvartal 2026

Bavarian Nordic reported Q1 2026 revenue of DKK 1,058 million, with Travel Health growing 14% driven by rabies and chikungunya vaccines, while Public Preparedness declined 53% as expected in a normalized year. The company upgraded full-year guidance to DKK 5,500-5,700 million revenue with ~28% EBITDA margin following a USD 97 million contract award from the U.S. government for freeze-dried smallpox vaccine production.

05/13/2026, 1:35 AM • GlobeNewswire

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has completed additional share repurchase transactions under its DKK 200 million buy-back program launched on March 12, 2026. As of May 1, 2026, the company has accumulated 900,295 repurchased shares at an average price of DKK 190.54, totaling DKK 171.5 million. Bavarian Nordic now holds 2,598,056 treasury shares, representing 3.28% of its share capital.

05/04/2026, 4:45 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S has completed additional share repurchases under its DKK 200 million buy-back program initiated on March 12, 2026. Between April 27 and May 1, 2026, the company repurchased 74,299 shares at an average price of DKK 185.62, bringing total accumulated repurchases to 900,295 shares (3.28% of share capital) valued at DKK 171.5 million.

05/04/2026, 4:45 AM • GlobeNewswire

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

Bavarian Nordic A/S has completed additional share repurchases under its DKK 200 million buy-back program initiated on March 12, 2026. Between April 20-24, 2026, the company repurchased 179,730 shares at an average price of DKK 191.09, bringing total accumulated repurchases to 825,996 shares (3.19% of share capital) worth DKK 157.8 million.

04/27/2026, 2:57 AM • GlobeNewswire

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

Bavarian Nordic A/S has announced transactions under its share buy-back program launched on March 12, 2026. Between April 20-24, 2026, the company repurchased 179,730 shares at an average price of 191.09 DKK, bringing total accumulated repurchases to 825,996 shares worth 157.8 million DKK. The company now holds 2,523,757 treasury shares, representing 3.19% of its share capital.

04/27/2026, 2:57 AM • GlobeNewswire

Resolutions of the Annual General Meeting 2026 of Bavarian Nordic A/S

Bavarian Nordic held its Annual General Meeting on April 21, 2026, adopting the 2025 Annual Report and approving most proposals including board elections, auditor re-election, and authorizations for share issuance and buybacks. However, the Remuneration Report for 2025 failed to gain approval in an indicative vote, prompting the board to discuss the decision and provide an explanatory statement in the 2026 report.

04/21/2026, 2:39 PM • GlobeNewswire

Beslutninger på den ordinære generalforsamling 2026 i Bavarian Nordic A/S

Bavarian Nordic A/S held its annual general meeting on April 21, 2026, approving the 2025 annual report and granting discharge to the board and management. The compensation report was rejected in a non-binding vote, prompting the board to review the decision. The board was expanded to seven members with three new appointments, and shareholders approved authorizations for capital increases, convertible bonds, warrants, and share buybacks. KPMG was reelected as auditor.

04/21/2026, 2:39 PM • GlobeNewswire

Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine

Bavarian Nordic announced that Swissmedic has approved VIMKUNYA, its recombinant chikungunya vaccine, for individuals aged 12 and above. This marks the fourth regulatory approval for the vaccine following FDA, EMA, and MHRA approvals in 2025. The company has also submitted an application to Health Canada for potential approval in the first half of 2026.

04/16/2026, 1:30 AM • GlobeNewswire